FRANZINI, MARIA
 Distribuzione geografica
Continente #
NA - Nord America 8.497
EU - Europa 6.429
AS - Asia 4.832
SA - Sud America 1.047
AF - Africa 111
Continente sconosciuto - Info sul continente non disponibili 91
OC - Oceania 11
Totale 21.018
Nazione #
US - Stati Uniti d'America 8.050
SG - Singapore 1.687
GB - Regno Unito 1.494
IT - Italia 1.482
CN - Cina 1.256
RU - Federazione Russa 1.242
BR - Brasile 836
VN - Vietnam 765
UA - Ucraina 491
PL - Polonia 357
DE - Germania 355
HK - Hong Kong 329
CA - Canada 313
BD - Bangladesh 294
FI - Finlandia 252
FR - Francia 185
DK - Danimarca 153
SE - Svezia 143
IN - India 94
IE - Irlanda 90
MX - Messico 84
AR - Argentina 76
NL - Olanda 63
ID - Indonesia 54
TR - Turchia 50
KR - Corea 48
IQ - Iraq 45
JP - Giappone 41
EC - Ecuador 38
ZA - Sudafrica 37
IL - Israele 32
ES - Italia 25
PK - Pakistan 24
CL - Cile 23
CO - Colombia 20
VE - Venezuela 18
LT - Lituania 17
MA - Marocco 17
AT - Austria 16
EU - Europa 16
UZ - Uzbekistan 15
MY - Malesia 14
PY - Paraguay 14
CH - Svizzera 13
SA - Arabia Saudita 13
SK - Slovacchia (Repubblica Slovacca) 12
PE - Perù 11
RO - Romania 11
AE - Emirati Arabi Uniti 10
CR - Costa Rica 10
EG - Egitto 10
KE - Kenya 10
JM - Giamaica 9
TW - Taiwan 9
DZ - Algeria 8
NP - Nepal 8
TN - Tunisia 8
AZ - Azerbaigian 6
JO - Giordania 6
NI - Nicaragua 6
PH - Filippine 6
AU - Australia 5
BE - Belgio 5
BO - Bolivia 5
SN - Senegal 5
TT - Trinidad e Tobago 5
KZ - Kazakistan 4
NO - Norvegia 4
PT - Portogallo 4
UY - Uruguay 4
AL - Albania 3
BB - Barbados 3
BY - Bielorussia 3
CI - Costa d'Avorio 3
DO - Repubblica Dominicana 3
ET - Etiopia 3
HN - Honduras 3
IR - Iran 3
MM - Myanmar 3
NZ - Nuova Zelanda 3
OM - Oman 3
AM - Armenia 2
GD - Grenada 2
GR - Grecia 2
NC - Nuova Caledonia 2
NG - Nigeria 2
PA - Panama 2
QA - Qatar 2
RS - Serbia 2
SR - Suriname 2
TH - Thailandia 2
AO - Angola 1
BF - Burkina Faso 1
BG - Bulgaria 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BT - Bhutan 1
CG - Congo 1
CU - Cuba 1
CZ - Repubblica Ceca 1
Totale 20.924
Città #
Dallas 1.337
Southend 1.186
Singapore 883
San Jose 587
Ashburn 582
Beijing 536
Chandler 413
Warsaw 351
Hong Kong 307
Council Bluffs 303
San Mateo 287
Pisa 245
Fairfield 240
Woodbridge 235
Jacksonville 230
Milan 217
Ann Arbor 208
Moscow 208
Houston 196
Ho Chi Minh City 174
Helsinki 164
Cambridge 162
Wilmington 161
The Dalles 151
Los Angeles 150
Seattle 147
Dong Ket 140
Dearborn 129
Hanoi 127
Falls Church 126
New York 126
Boardman 121
Rome 100
Columbus 93
Stevenage 92
Hefei 91
Santa Clara 90
Beauharnois 86
São Paulo 85
Dublin 84
Portsmouth 82
Ottawa 80
Lauterbourg 77
Lawrence 74
Buffalo 63
Brooklyn 46
Montréal 40
Munich 39
Montreal 38
Tokyo 36
Bologna 35
Chicago 35
Mexico City 34
Figino 33
Orem 33
Seoul 33
Da Nang 32
Turin 32
London 31
Rio de Janeiro 28
Tel Aviv 28
Toronto 28
San Diego 27
Johannesburg 26
Naples 25
Amsterdam 24
Denver 24
Florence 24
Haiphong 22
San Francisco 21
Atlanta 20
Boston 20
Brasília 20
Chennai 20
Kansas City 20
Phoenix 20
Redwood City 20
Stockholm 20
Baghdad 18
Frankfurt am Main 18
Manchester 16
Catania 15
Old Bridge 15
Poplar 15
Nuremberg 14
Tashkent 14
Ankara 13
Biên Hòa 13
Norwalk 13
Potenza 13
Quito 13
Santiago 13
Charlotte 12
Istanbul 12
Jakarta 12
North Bergen 12
Palermo 12
Pavia 12
Redondo Beach 12
Shanghai 12
Totale 12.759
Nome #
A High Performance Gel Filtration Chromatography Method for gamma-Glutamyltransferase Fraction Analysis 462
Value of the HFA-PEFF and H2FPEF scores in patients with heart failure and preserved ejection fraction caused by cardiac amyloidosis 451
Accuracy of b-GGT fraction for the diagnosis of non-alcoholic fatty liver disease. 430
b-Gamma-glutamyltransferase activity in human vulnerable carotid plaques. 403
Accuracy of b-GGT fraction for the diagnosis of non-alcoholic fatty liverdisease. 387
Cardiac biomarker testing in the clinical laboratory: Where do we stand? General overview of the methodology with special emphasis on natriuretic peptides 375
Gamma-glutammiltransferasi (GGT): biochimica clinica e patologia umana (Rassegna) 358
A role for gamma-glutamyltransferase in pathogenesis and evolution of cardiovascular diseases. 342
Comparison between BNP values measured in capillary blood samples with a POCT method and those measured in plasma venous samples with an automated platform 337
Clinical implications of a recent adjustment to the high-sensitivity cardiac troponin T assay: some results. 336
Cardiovascular risk factors and gamma-glutamyltransferase fractions in healthy individuals 329
The calculation of the cardiac troponin T 99th percentile of the reference population is affected by age, gender, and population selection: A multicenter study in Italy. 319
Cardiovascular risk factors and gamma-glutamyltransferase fractions in healthy individuals. 313
Biomarcatori di stabilità della placca aterosclerotica (Rassegna) 307
Valutazione delle caratteristiche analitiche di un nuovo metodo di dosaggio del BNP 302
Evaluation of analytical performance of a novel immunoenzymometric assay for cTnI. 296
Antioxidant capacity and protein oxidation in cerebrospinal fluid of amyotrophic lateral sclerosis. 287
Cardiac biomarker testing in the clinical laboratory:Where do we stand? General overview of the methodology with special emphasis on natriuretic peptides. 287
Natriuretic peptides as biomarkers of cardiac endocrine function in heart failure: New challenges and perspectives 286
A kinetic study of gamma-glutamyltransferase (GGT)-mediated S-nitrosoglutathione catabolism. 281
Big gamma-glutamyltransferase is associated with epicardial fat volume and cardiovascular outcome in the general population 277
RNA-targeting and gene editing therapies for transthyretin amyloidosis 275
Circulating gamma-glutamyltransferase fractions in cirrhosis. 274
Marcatori di rimodellamento e fibrosi cardiaca 271
Aortic valve disease and gamma-glutamyltransferase: accumulation in tissue and relationships with calcific degeneration. 271
Indici di laboratorio di stress ossidativo. 270
Wild-type transthyretin cardiac amyloidosis is not rare in elderly subjects: the CATCH screening study 268
Oxidative stress and inflammation in the evolution of heart failure: From pathophysiology to therapeutic strategies 267
A novel marker of progression for atherosclerosis and cardiovascular diseases: serum gamma-glutamyltransferase enzyme activity. 262
Forme molecolari della gamma-glutammiltransferasi: caratteristiche e biogenesis. 256
Are standard cell culture conditions adequate for human umbilical cord blood mesenchymal stem cells? 256
Stato dell’arte dell’immunodosaggio dei peptidi natriuretici di tipo B 254
Criteri per la valutazione delle caratteristiche analitiche e della utilità clinica dei nuovi biomarcatori cardiaci 251
gamma-Glutamyltransferase activity in human atherosclerotic plaques – biochemical similarities with the circulating enzyme. 246
Rilevanza clinica e interpretazione dei marcatori biochimici nello scompenso cardiaco 241
Myocardial Infarction Following COVID-19 Vaccine Administration: Post Hoc, Ergo Propter Hoc? 240
State of the art of aldosterone immunoassays. A multicenter collaborative study on the behalf of the Cardiovascular Biomarkers Study Group of the Italian Section of European Society of Ligand Assay (ELAS) and Società Italiana di Biochimica Clinica (SIBIOC). 237
Correlates and reference limits of plasma gamma-glutamyltransferase fractions from the Framingham Heart Study. 232
The IL-33/ST2 pathway, inflammation and atherosclerosis: Trigger and target? 230
Antithrombotic properties of Tafamidis: An additional protective effect for transthyretin amyloid cardiomyopathy patients 218
State of the art of BNP and NT-proBNP immunoassays: The CardioOrmoCheck study. 217
Reference values for alanine aminotransferase, α-amylase, aspartate aminotransferase, γ-glutamyltransferase and lactate dehydrogenase measured according to the IFCC standardization during uncomplicated pregnancy. 215
Systematic differences between BNP immunoassays: comparison of methods using standard protocols and quality control materials 214
State of the art of aldosterone immunoassays. 214
State of the Art of Immunoassay Methods for B-Type Natriuretic Peptides: an Update 213
The potential roles of gamma-glutamyltransferase activity in the progression of atherosclerosis and cardiovascular diseases. 213
The S-thiolating activity of membrane gamma-glutamyltransferase: formation of cysteinyl-glycine mixed disulfides with cellular proteins and in the cell microenvironment. 209
Valutazione di un metodo di dosaggio del BNP nel sangue capillare 208
Valutazione delle prestazioni analitiche del nuovo metodo per il dosaggio dell’aldosterone che utilizza la piattaforma LIAISON: confronto con altri metodi immunometrcici e con la psettrometria di massa 203
Gamma-glutamyltransferase fractions in human plasma and bile: Characteristic and biogenesis 203
Mechanisms and targets of the modulatory action of S-nitrosoglutathione (GSNO) on inflammatory cytokines expression. 203
Fractions of plasma gamma-glutamyltransferase in healthy individuals: Reference values. 200
Contribution by polymorphonucleate granulocytes to elevated gamma-glutamyltransferase in cystic fibrosis sputum. 200
Biomarkers for growth prediction of abdominal aortic aneurysm: A step forward(?) 199
Big and Free Fractions of Gamma-Glutamyltransferase: New Diagnostic Biomarkers for Malignant Mesothelioma? 198
Serum gamma-glutamyltransferase: linking together environmental pollution, redox equilibria and progression of atherosclerosis? 198
Transthyretin Stabilizers and Seeding Inhibitors as Therapies for Amyloid Transthyretin Cardiomyopathy 195
Developmental variations of plasma gamma-glutamyltransferase fractions in humans and in laboratory mammalians. 191
Serum gamma-glutamyltransferase and intima-media thickness: pointing again to wall/lumen interactions in atherosclerosis. 189
Forme molecolari dela gamma-glutammiltransferasi: caratteristiche e biogenesi 189
gamma-glutamiltransferasi e stress ossidativo. 185
Method of detecting and separating serum gamma-glutamyltransferase (GGT) isoforms in a sample of biological fluid and the enzyme isoforms thereby obtained 185
Gamma-glutamyltransferase, H(2)O(2)-induced apoptosis and expression of catalase. 185
Stato dell’arte del dosaggio dei peptidi BNP e NT-proBNP: il controllo di qualità esterno CardioOrmoCheck 185
Vitamin C supply to bronchial epithelial cells linked to glutathione availability in elf - A role for secreted gamma-glutamyltransferase. 184
Gamma-glutamyltransferase of cancer cells at the crossroads of tumor progression, drug resistance and drug targeting 184
Pathophysiology of Cardiac Amyloidosis 182
γ-Glutamyltransferase Fractions in Obese Subjects with Type 2 Diabetes: Relation to Insulin Sensitivity and Effects of Bariatric Surgery 182
gamma-Glutamyl transpeptidase catalyses the extracellular detoxification of cisplatin in a human cell line derived from the proximal convoluted tubule of the kidney. 181
Cultured human cells release soluble gamma-glutamyltransferase complexes corresponding to the plasma b-GGT 181
Cystic fibrosis, elevated gamma-glutamyltransferase, and lung transplant outcome. 180
Prevalence and clinical outcomes of isolated or combined moderate to severe mitral and tricuspid regurgitation in patients with cardiac amyloidosis 178
PROCESS FOR DETERMINING S-NITROSOTHIOLS IN BIOLOGICALFLUIDS 178
Helicobacter, gamma-glutamyltransferase and cancer: further intriguing connections 177
High-sensitivity gamma-glutamyltransferase fraction pattern in alcohol addicts and abstainers. 174
Plasma membrane gamma-glutamyltransferase activity facilitates the uptake of vitamin C in melanoma cells. 173
Serum gamma-glutamyltransferase fractions in Myotonic Dystrophy type I: Differences with healthy subjects and patients with liver disease. 173
Use of biomarkers to diagnose and manage cardiac amyloidosis 173
Exogenous vs. endogenous gamma-glutamyltransferase activity: Implications for the specific determination of S-nitrosoglutathione in biological samples. 172
The Journey of Human Transthyretin: Synthesis, Structure Stability, and Catabolism 168
Tetrameric Transthyretin as a Protective Factor Against Alzheimer’s Disease 166
Highly Elevated Plasma γ-Glutamyltransferase Elevations: A Trait Caused by γ-Glutamyltransferase 1 Transmembrane Mutations 165
Modulation of cell growth and cisplatin sensitivity by membrane gamma-glutamyltransferase in melanoma cells. 162
Gamma-glutamyltransferases: exploring the complexity of a multifunctional family of enzymes 158
Plasma gamma-glutamyltransferase (GGT) activity in inflammatory bowel disease: is the clinical laboratory plasma GGT assay sensitive enough for gastroenterology? 152
Right ventricular to pulmonary artery coupling and outcome in patients with cardiac amyloidosis 145
Preliminary study to evaluate the meaning of GGT fractions analysis in a population of workers previously exposed to asbestos 131
Biological variability of transthyretin in patients with transthyretin cardiac amyloidosis: implications for therapy monitoring 79
Current Standards and Perspectives in Proteomics for Cardiac Amyloidosis 66
Serum and Tissue Light-Chains as Disease Biomarkers in AL Amyloidosis 65
Profiling plasma transthyretin in healthy subjects and patients with cardiac ATTR amyloidosis by native electrophoresis 51
Reflection-mode fiber optic biosensor integrating FBG and short period-LPG for real-time detection of fPSA 43
Totale 21.018
Categoria #
all - tutte 100.130
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 100.130


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.034 0 222 40 77 27 28 128 219 66 132 18 77
2022/2023965 80 31 26 163 142 177 19 74 178 15 41 19
2023/2024543 50 24 76 27 17 74 47 44 19 21 48 96
2024/20253.226 46 36 148 77 121 199 506 964 234 143 513 239
2025/20269.370 401 1.494 987 1.141 821 568 1.102 386 582 647 501 740
2026/2027526 251 275 0 0 0 0 0 0 0 0 0 0
Totale 21.018